修正:がん治療のためのポリメリックナノキャリア: 敏感なポリ ((2- ((イソプロピラミノ) エチルメタクリlateの約束)
Joana S Ferreira1, João P Vareda1, A S Oliveira1
1University of Coimbra, Centre for Mechanical Engineering, Materials and Processes, Department of Chemical Engineering, Rua Sílvio Lima-Polo II, 3030-790 Coimbra, Portugal. patmend@eq.uc.pt.
Journal of materials chemistry. B
|August 29, 2025
まとめ
この訂正は,がん治療のためのポリメリックナノキャリアに関する詳細を明確にし,特に敏感なポリ ((2- ((イソプロピラミノエチルメタクリlate) 材料に焦点を当てています. 更新された情報は,この有望ながん治療法の科学的記録の正確さを保証します.
科学分野:
- 材料科学
- ポリマー化学
- ナノテクノロジー
関連する概念動画
Modified-Release Drug Delivery Systems: Site-Targeted
167
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
167
Site-Targeted Drug Delivery Systems: Polymeric Carriers
165
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
165


